Gynecomastia in Adolescent Males

Abstract

Gynecomastia is defined as an enlargement of the male breast. It is often benign, and can be the source of significant embarrassment and psychological distress. A general medical history and careful physical examination are essential to distinguish normal developmental variants from pathological causes. Treatment is geared toward the specific etiology when identified. In the majority of cases of pubertal gynecomastia, observation and reassurance are the mainstays of therapy as the condition usually resolves naturally. Pharmacological treatment and surgery are recommended only in selected cases.

Keywords

Gynecomastia - adolescent - surgical treatment - ultrasound-assisted liposuction

• References

• 1 Braunstein GD. Gynecomastia. N Engl J Med 1993; 328 (7) 490-495
• 2 Bembo SA, Carlson HE. Gynecomastia: its features, and when and how to treat it. Cleve Clin J Med 2004; 71 (6) 511-517
• 3 Ma NS, Geffner ME. Gynecomastia in prepubertal and pubertal men. Curr Opin Pediatr 2008; 20 (4) 465-470
• 4 Kumanov P, Deepinder F, Robeva R, Tomova A, Li J, Agarwal A. Relationship of adolescent gynecomastia with varicocele and somatometric parameters: a cross-sectional study in 6200 healthy boys. J Adolesc Health 2007; 41 (2) 126-131
• 5 Nuttall FQ. Gynecomastia as a physical finding in normal men. J Clin Endocrinol Metab 1979; 48 (2) 338-340
• 6 Niewoehner CB, Nuttal FQ. Gynecomastia in a hospitalized male population. Am J Med 1984; 77 (4) 633-638
• 7 Nydick M, Bustos J, Dale Jr JH, Rawson RW. Gynecomastia in adolescent boys. JAMA 1961; 178: 449-454
• 8 Lemaine V, Simmons PS. The adolescent female: Breast and reproductive embryology and anatomy. Clin Anat 2013; 26 (1) 22-28
• 9 Abaci A, Buyukgebiz A. Gynecomastia: review. Pediatr Endocrinol Rev 2007; 5 (1) 489-499
• 10 Moore DC, Schlaepfer LV, Paunier L, Sizonenko PC. Hormonal changes during puberty: V. Transient pubertal gynecomastia: abnormal androgen-estrogen ratios. J Clin Endocrinol Metab 1984; 58 (3) 492-499
• 11 Mathur R, Braunstein GD. Gynecomastia: pathomechanisms and treatment strategies. Horm Res 1997; 48 (3) 95-102
• 12 Lee PA. The relationship of concentrations of serum hormones to pubertal gynecomastia. J Pediatr 1975; 86 (2) 212-215
• 13 LaFranchi SH, Parlow AF, Lippe BM, Coyotupa J, Kaplan SA. Pubertal gynecomastia and transient elevation of serum estradiol level. Am J Dis Child 1975; 129 (8) 927-931
• 14 Bidlingmaier F, Knorr D. Plasma testosterone and estrogens in pubertal gynecomastia. Z Kinderheilkd 1973; 115 (1) 89-94
• 15 Biro FM, Lucky AW, Huster GA, Morrison JA. Hormonal studies and physical maturation in adolescent gynecomastia. J Pediatr 1990; 116 (3) 450-455
• 16 Sher ES, Migeon CJ, Berkovitz GD. Evaluation of boys with marked breast development at puberty. Clin Pediatr (Phila) 1998; 37 (6) 367-371
• 17 Evans DG, Bulman M, Young K , et al. BRCA1/2 mutation analysis in male breast cancer families from North West England. Fam Cancer 2008; 7 (2) 113-117
• 18 Beckenstein MS, Windle BH, Stroup Jr RT. Anatomical parameters for nipple position and areolar diameter in males. Ann Plast Surg 1996; 36 (1) 33-36
• 19 Murphy TP, Ehrlichman RJ, Seckel BR. Nipple placement in simple mastectomy with free nipple grafting for severe gynecomastia. Plast Reconstr Surg 1994; 94 (6) 818-823
• 20 Bannayan GA, Hajdu SI. Gynecomastia: clinicopathologic study of 351 cases. Am J Clin Pathol 1972; 57 (4) 431-437
• 21 Maidment SL. Question 2. Which medications effectively reduce pubertal gynaecomastia?. Arch Dis Child 2010; 95 (3) 237-239
• 22 Petty PM, Solomon M, Buchel EW, Tran NV. Gynecomastia: evolving paradigm of management and comparison of techniques. Plast Reconstr Surg 2010; 125 (5) 1301-1308
• 23 Buckle R. Danazol therapy in gynaecomastia; recent experience and indications for therapy. Postgrad Med J 1979; 55 (Suppl. 05) 71-78
• 24 Buckle R. Studies on the treatment of gynaecomastia with danazol (Danol). J Int Med Res 1977; 5 (Suppl. 03) 114-123
• 25 Zachmann M, Eiholzer U, Muritano M, Werder EA, Manella B. Treatment of pubertal gynaecomastia with testolactone. Acta Endocrinol Suppl (Copenh) 1986; 279: 218-226
• 26 Derman O, Kanbur NO, Kutluk T. Tamoxifen treatment for pubertal gynecomastia. Int J Adolesc Med Health 2003; 15 (4) 359-363
• 27 Derman O, Kanbur NO, Tokur TE. The effect of tamoxifen on sex hormone binding globulin in adolescents with pubertal gynecomastia. J Pediatr Endocrinol Metab 2004; 17 (8) 1115-1119
• 28 Plourde PV, Reiter EO, Jou HC , et al. Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2004; 89 (9) 4428-4433
• 29 Lawrence SE, Faught KA, Vethamuthu J, Lawson ML. Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. J Pediatr 2004; 145 (1) 71-76
• 30 Simon BE, Hoffman S, Kahn S. Classification and surgical correction of gynecomastia. Plast Reconstr Surg 1973; 51 (1) 48-52
• 31 Rohrich RJ, Ha RY, Kenkel JM, Adams Jr WP. Classification and management of gynecomastia: defining the role of ultrasound-assisted liposuction. Plast Reconstr Surg 2003; 111 (2) 909-923 , discussion 924–925
• 32 Fruhstorfer BH, Malata CM. A systematic approach to the surgical treatment of gynaecomastia. Br J Plast Surg 2003; 56 (3) 237-246
• 33 Webster JP. Mastectomy for gynecomastia through a semicircular intra-areolar incision. Ann Surg 1946; 124 (3) 557-575
• 34 Morselli PG. “Pull-through”: a new technique for breast reduction in gynecomastia. Plast Reconstr Surg 1996; 97 (2) 450-454
• 35 Morselli PG, Morellini A. Breast reshaping in gynecomastia by the “pull-through technique”: considerations after 15 years. Eur J Plast Surg 2012; 35 (5) 365-371
• 36 Hammond DC, Arnold JF, Simon AM, Capraro PA. Combined use of ultrasonic liposuction with the pull-through technique for the treatment of gynecomastia. Plast Reconstr Surg 2003; 112 (3) 891-895 , discussion 896–897
• 37 Lista F, Ahmad J. Power-assisted liposuction and the pull-through technique for the treatment of gynecomastia. Plast Reconstr Surg 2008; 121 (3) 740-747